Key marijuana drug approval looms as cannabis goes mainstream

FILE PHOTO: Charlotte Caldwell, and her son Billy, sit outside the Home Office during a break in a meeting with officials to discuss how Billy can have his severe epilepsy treated with cannabis oil, which is a banned substance in Britain, in London, June 11, 2018. REUTERS/Peter Nicholls/File Photo

LONDON (Reuters) – Evidence that cannabis can ease epilepsy and other conditions is building as a British company counts down to what would be the first U.S. government approval for a prescription drug derived from the marijuana plant. GW Pharmaceuticals, which has spent 20 years developing medicines from cannabis, is hoping for a Food and […]

Continue reading this article with a Fiji Times online membership.

More Stories